Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob

A conditionally replicative adenovirus is a novel anticancer agent designed to replicate selectively in tumor cells. However, a leak of the virus into systemic circulation from the tumors often causes ectopic infection of various organs. Therefore, suppression of naive viral tropism and addition of tumor-targeting potential are necessary to secure patient safety and increase the therapeutic effect of an oncolytic adenovirus in the clinical setting. We have recently developed a direct selection method of targeted vector from a random peptide library displayed on an adenoviral fiber knob to overcome the limitation that many cell type-specific ligands for targeted adenovirus vectors are not known. Here we examined whether the addition of a tumor-targeting ligand to a replication-competent adenovirus ablated for naive tropism enhances its therapeutic index. First, a peptide-display adenovirus library was screened on a pancreatic cancer cell line (AsPC-1), and particular peptide sequences were selected. The replication-competent adenovirus displaying the selected ligand (AdΔCAR-SYE) showed higher oncolytic potency in several other pancreatic caner cell lines as well as AsPC-1 compared with the untargeted adenovirus (AdΔCAR). An intratumoral injection of AdΔCAR-SYE significantly suppressed the growth of AsPC-1 subcutaneous tumors, and an analysis of adenovirus titer in the tumors revealed an effective replication of the virus in the tumors. Ectopic liver gene transduction following the intratumoral injection of AdΔCAR-SYE was not increased compared with the AdΔCAR. The results showed that a tumor-targeting strategy using an adenovirus library is promising for optimizing the safety and efficacy of oncolytic adenovirus therapy.

[1]  S. J. White,et al.  In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors , 2004, The journal of gene medicine.

[2]  T. Shigehisa,et al.  Effects of recloning on the efficiency of production of alpha 1,3-galactosyltransferase knockout pigs. , 2008, The Journal of reproduction and development.

[3]  S. Toyokuni,et al.  Anchorage-Independent Growth of Mouse Male Germline Stem Cells In Vitro1 , 2006, Biology of reproduction.

[4]  K. Yoshitomo-Nakagawa,et al.  Cloning, expression analysis, and chromosomal localization of BH-protocadherin (PCDH7), a novel member of the cadherin superfamily. , 1998, Genomics.

[5]  M. Oshimura,et al.  Production of knockout mice by random or targeted mutagenesis in spermatogonial stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Engelhardt,et al.  Bioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia. , 2007, American journal of respiratory cell and molecular biology.

[7]  G. Nabel,et al.  Molecular Medicine © 1999 The Picower Institute Press Efficient Generation of Recombinant Adenoviral Vectors by Cre-lox Recombination In Vitro , 1999 .

[8]  C. Miller,et al.  A system for the propagation of adenoviral vectors with genetically modified receptor specificities , 1999, Nature Biotechnology.

[9]  Fyodor D Urnov,et al.  Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases , 2007, Proceedings of the National Academy of Sciences.

[10]  P. Currie,et al.  Animal models of human disease: zebrafish swim into view , 2007, Nature Reviews Genetics.

[11]  T. Sugimura,et al.  Establishment of a human pancreatic adenocarcinoma cell line (PSN-1) with amplifications of both c-myc and activated c-Ki-ras by a point mutation. , 1986, Biochemical and biophysical research communications.

[12]  C. Balagué,et al.  Replicative adenoviruses for cancer therapy , 2000, Nature Biotechnology.

[13]  A. Asai,et al.  Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas. , 1999, Cancer research.

[14]  J. Engler,et al.  Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector. , 2005, Biochemical and biophysical research communications.

[15]  Lianchun Fan,et al.  Homologous Recombination in Zebrafish ES Cells , 2006, Transgenic Research.

[16]  M. Lamfers,et al.  Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors , 2003, Gene Therapy.

[17]  Teruhiko Yoshida,et al.  Development of gene therapy to target pancreatic cancer , 2004, Cancer science.

[18]  I. Kovesdi,et al.  Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression , 1997, Journal of virology.

[19]  L. Young,et al.  Viral gene therapy strategies: from basic science to clinical application , 2006, The Journal of pathology.

[20]  Stuart A Nicklin,et al.  The influence of adenovirus fiber structure and function on vector development for gene therapy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  K. Brand,et al.  Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection , 1999, Gene Therapy.

[22]  M. Kay,et al.  A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob , 2001, Gene Therapy.

[24]  Toni Cathomen,et al.  Zinc-finger Nucleases: The Next Generation Emerges. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Lung-Ji Chang,et al.  Efficient generation of transgenic rats through the male germline using lentiviral transduction and transplantation of spermatogonial stem cells. , 2006, Journal of andrology.

[26]  David K. Meyerholz,et al.  Disruption of the CFTR Gene Produces a Model of Cystic Fibrosis in Newborn Pigs , 2008, Science.

[27]  P. Gregory,et al.  Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.

[28]  R. Brinster,et al.  Technology Insight: in vitro culture of spermatogonial stem cells and their potential therapeutic uses , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[29]  S. Goodison,et al.  A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Δ24, for the treatment of advanced breast cancer , 2007, Gene Therapy.

[30]  R. Alemany,et al.  A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  D. Curiel,et al.  Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob , 2007, Gene Therapy.

[32]  S. Toyokuni,et al.  Leukemia Inhibitory Factor Enhances Formation of Germ Cell Colonies in Neonatal Mouse Testis Culture1 , 2007, Biology of reproduction.

[33]  W. Zeng,et al.  Adeno‐associated virus (AAV)‐mediated transduction of male germ line stem cells results in transgene transmission after germ cell transplantation , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  M. Bonin,et al.  Generation of pluripotent stem cells from adult human testis , 2008, Nature.

[35]  Lianchun Fan,et al.  Zebrafish embryonic stem cells. , 2006, Methods in Enzymology.

[36]  T. Hocking,et al.  Heritable Targeted Gene Disruption in Zebrafish Using Designed Zinc Finger Nucleases , 2008, Nature Biotechnology.

[37]  M. Porteus.  Design and testing of zinc finger nucleases for use in mammalian cells. , 2008, Methods in molecular biology.

[38]  D. Curiel,et al.  Targeted and shielded adenovectors for cancer therapy , 2006, Cancer Immunology, Immunotherapy.

[39]  I. Dobrinski.  Transplantation of germ line stem cells for the study and manipulation of spermatogenesis. , 2006, Ernst Schering Research Foundation workshop.

[40]  M. Welsh,et al.  Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. , 2008, The Journal of clinical investigation.

[41]  S. Burgess,et al.  Using retroviruses as a mutagenesis tool to explore the zebrafish genome. , 2008, Briefings in functional genomics & proteomics.

[42]  J. Bachevalier,et al.  Towards a transgenic model of Huntington’s disease in a non-human primate , 2008, Nature.

[43]  W. Sanger,et al.  Producing primate embryonic stem cells by somatic cell nuclear transfer , 2007, Nature.

[44]  M. Noyes,et al.  Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases , 2008, Nature Biotechnology.

[45]  I. Kovesdi,et al.  Reducing the Native Tropism of Adenovirus Vectors Requires Removal of both CAR and Integrin Interactions , 2001, Journal of Virology.

[46]  Xingshen Sun,et al.  Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. , 2008, The Journal of clinical investigation.

[47]  M. Safioleas,et al.  Pancreatic cancer today. , 2004, Hepato-gastroenterology.

[48]  A. Klug,et al.  Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases , 2008, Proceedings of the National Academy of Sciences.

[49]  M. Oshimura,et al.  Production of knockout mice by gene targeting in multipotent germline stem cells. , 2007, Developmental biology.

[50]  D. Curiel,et al.  Current developments in adenovirus-based cancer gene therapy. , 2006, Future oncology.

[51]  D. Nettelbeck,et al.  Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. , 2002, Cancer research.

[52]  Drena Dobbs,et al.  Zinc Finger Database (ZiFDB): a repository for information on C2H2 zinc fingers and engineered zinc-finger arrays , 2008, Nucleic Acids Res..

[53]  V. Prince,et al.  Current perspectives in zebrafish reverse genetics: Moving forward , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[54]  Wadih Arap,et al.  Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors , 2003, Nature Biotechnology.

[55]  J. Nemunaitis,et al.  Oncolytic viral therapies , 2004, Cancer Gene Therapy.

[56]  J. Orange,et al.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.

[57]  B. Liu,et al.  Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule. , 2001, Cancer research.

[58]  B. Trapnell,et al.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.

[59]  G. Nemerow,et al.  Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[60]  Y. Kitade,et al.  Adenovirus-mediated interferon α gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer , 2005, British Journal of Cancer.

[61]  I. Dobrinski.  Male germ cell transplantation. , 2008, Reproduction in domestic animals = Zuchthygiene.

[62]  C. Napoli,et al.  Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer , 2008, Cell.

[63]  H. Kato,et al.  BH‐protocadherin‐c, a member of the cadherin superfamily, interacts with protein phosphatase 1 alpha through its intracellular domain , 1999, FEBS letters.

[64]  J. T. Fisher,et al.  The porcine lung as a potential model for cystic fibrosis. , 2008, American journal of physiology. Lung cellular and molecular physiology.